These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22913878)

  • 21. The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism.
    Heinrichs M; Ashour D; Siegel J; Büchner L; Wedekind G; Heinze KG; Arampatzi P; Saliba AE; Cochain C; Hofmann U; Frantz S; Campos Ramos G
    Cardiovasc Res; 2021 Nov; 117(13):2664-2676. PubMed ID: 34048536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of structural motifs critical for epstein-barr virus-induced molecule 2 function and homology modeling of the ligand docking site.
    Zhang L; Shih AY; Yang XV; Kuei C; Wu J; Deng X; Mani NS; Mirzadegan T; Sun S; Lovenberg TW; Liu C
    Mol Pharmacol; 2012 Dec; 82(6):1094-103. PubMed ID: 22930711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural motifs of importance for the constitutive activity of the orphan 7TM receptor EBI2: analysis of receptor activation in the absence of an agonist.
    Benned-Jensen T; Rosenkilde MM
    Mol Pharmacol; 2008 Oct; 74(4):1008-21. PubMed ID: 18628402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.
    Bürkle A; Niedermeier M; Schmitt-Gräff A; Wierda WG; Keating MJ; Burger JA
    Blood; 2007 Nov; 110(9):3316-25. PubMed ID: 17652619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma.
    Vermi W; Lonardi S; Bosisio D; Uguccioni M; Danelon G; Pileri S; Fletcher C; Sozzani S; Zorzi F; Arrigoni G; Doglioni C; Ponzoni M; Facchetti F
    J Pathol; 2008 Nov; 216(3):356-64. PubMed ID: 18792075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice.
    Zhang Q; Cao DL; Zhang ZJ; Jiang BC; Gao YJ
    J Neuroinflammation; 2016 Jul; 13(1):183. PubMed ID: 27401148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR5+ CCR7- CD8 T cells are early effector memory cells that infiltrate tonsil B cell follicles.
    Quigley MF; Gonzalez VD; Granath A; Andersson J; Sandberg JK
    Eur J Immunol; 2007 Dec; 37(12):3352-62. PubMed ID: 18000950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCL13 responsiveness but not CXCR5 expression by late transitional B cells initiates splenic white pulp formation.
    Neely HR; Flajnik MF
    J Immunol; 2015 Mar; 194(6):2616-23. PubMed ID: 25662995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer.
    Ma D; Fan SB; Hua N; Li GH; Chang Q; Liu X
    Curr Cancer Drug Targets; 2020; 20(5):355-363. PubMed ID: 31899677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma.
    Chan CC; Shen D; Hackett JJ; Buggage RR; Tuaillon N
    Ophthalmology; 2003 Feb; 110(2):421-6. PubMed ID: 12578791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCL13 antibody for the treatment of autoimmune disorders.
    Klimatcheva E; Pandina T; Reilly C; Torno S; Bussler H; Scrivens M; Jonason A; Mallow C; Doherty M; Paris M; Smith ES; Zauderer M
    BMC Immunol; 2015 Feb; 16(1):6. PubMed ID: 25879435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCR5 overexpression in HL-60 cells enhances chemotaxis toward CXCL13 without anticipated interaction partners or enhanced MAPK signaling.
    MacDonald RJ; Yen A
    In Vitro Cell Dev Biol Anim; 2018 Dec; 54(10):725-735. PubMed ID: 30276608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver.
    Meijer J; Zeelenberg IS; Sipos B; Roos E
    Cancer Res; 2006 Oct; 66(19):9576-82. PubMed ID: 17018614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RelA driven co-expression of CXCL13 and CXCR5 is governed by a multifaceted transcriptional program regulating breast cancer progression.
    Biswas S; Roy Chowdhury S; Mandal G; Purohit S; Gupta A; Bhattacharyya A
    Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):502-511. PubMed ID: 30553016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCR5 is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking.
    Wiener A; Schippers A; Wagner N; Tacke F; Ostendorf T; Honke N; Tenbrock K; Ohl K
    Clin Exp Immunol; 2016 Jul; 185(1):22-32. PubMed ID: 26990531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine.
    Duan Z; Chen X; Liang Z; Zeng Y; Zhu F; Long L; McCrae MA; Zhuang H; Shen T; Lu F
    Vaccine; 2014 Sep; 32(41):5316-22. PubMed ID: 25077417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.
    Li Y; Wang W; Tang L; He X; Yan X; Zhang X; Zhu Y; Sun J; Shi Y; Ma X; Mackay IR; Gershwin ME; Han Y; Hou J
    Hepatology; 2015 Jun; 61(6):1998-2007. PubMed ID: 25627620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand modulation of the Epstein-Barr virus-induced seven-transmembrane receptor EBI2: identification of a potent and efficacious inverse agonist.
    Benned-Jensen T; Smethurst C; Holst PJ; Page KR; Sauls H; Sivertsen B; Schwartz TW; Blanchard A; Jepras R; Rosenkilde MM
    J Biol Chem; 2011 Aug; 286(33):29292-29302. PubMed ID: 21673108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCL13/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma.
    Liu JF; Lee CW; Lin CY; Chao CC; Chang TM; Han CK; Huang YL; Fong YC; Tang CH
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.
    Singh S; Singh R; Singh UP; Rai SN; Novakovic KR; Chung LW; Didier PJ; Grizzle WE; Lillard JW
    Int J Cancer; 2009 Nov; 125(10):2288-95. PubMed ID: 19610059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.